Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 801 to 825 of 2570

TitleReference numberPublishedLast updated
Pelvic floor dysfunction: prevention and non-surgical managementNG210
Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal)TA750
Dupilumab for treating severe asthma with type 2 inflammationTA751
FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndromeMIB281
Brain tumours (primary) and brain metastases in over 16sQS203
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disordersTA748
Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal)TA749
clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemiaMIB278
CerebAir for continuous EEG monitoring in intensive careMIB279
Paige Prostate for prostate cancerMIB280
Synergo for non-muscle-invasive bladder cancerHTG601
Fever in under 5s: assessment and initial managementNG143
Givosiran for treating acute hepatic porphyriaHST16
Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failureHTG599
Coronary sinus narrowing device implantation for refractory anginaHTG600
Chronic kidney disease: assessment and managementNG203
SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoeaHTG598
Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancerTA746
Nintedanib for treating progressive fibrosing interstitial lung diseasesTA747
Acute heart failure: diagnosis and managementCG187
Heart valve disease presenting in adults: investigation and managementNG208
Upadacitinib for treating moderate rheumatoid arthritisTA744
NBTXR-3 for treating advanced soft tissue sarcoma (terminated appraisal)TA745
Inducing labourQS60
Inducing labourNG207

Results per page

  1. 10
  2. 25
  3. 50
  4. All